Clovis Oncology Hits Ch. 11 With $754.5M Debt And Sale Plans
By Jeff Montgomery · December 12, 2022, 10:21 AM EST
Clovis Oncology Inc. took its cancer-focused biopharmaceutical business into Chapter 11 in Delaware bankruptcy court on Sunday, reporting $319 million in assets and $754.5 million in debt, with a stalking horse...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login